3//SEC Filing
Novartis Institutes for BioMedical Research, Inc. 3
Accession 0000899243-18-008659
CIK 0001661998other
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 6:25 PM ET
Size
6.5 KB
Accession
0000899243-18-008659
Insider Transaction Report
Form 3
Holdings
Series B Preferred Stock
→ Common Stock (1,979,226 underlying)
Footnotes (2)
- [F1]The preferred stock is convertible into the Issuer's common stock on a one-for-one basis at the holder's election and has no expiration date. The preferred stock will automatically convert into common stock upon the closing of the Issuer's initial public offering.
- [F2]The securities reported herein are held of record by Novartis Institutes for BioMedical Research, Inc. ("NIBRI"). NIBRI is an indirect wholly-owned subsidiary of Novartis AG. Novartis AG may therefore be deemed to have or share beneficial ownership of the Series B Preferred Stock held directly by NIBRI.
Documents
Issuer
Homology Medicines, Inc.
CIK 0001661998
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001673852
Filing Metadata
- Form type
- 3
- Filed
- Mar 26, 8:00 PM ET
- Accepted
- Mar 27, 6:25 PM ET
- Size
- 6.5 KB